These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 17049720)
1. Designing a new generation of anti-hCG vaccines for cancer therapy. Delves PJ; Iles RK; Roitt IM; Lund T Mol Cell Endocrinol; 2007 Jan; 260-262():276-81. PubMed ID: 17049720 [TBL] [Abstract][Full Text] [Related]
2. Human chorionic gonadotropin as a target for cancer vaccines. Triozzi PL; Stevens VC Oncol Rep; 1999; 6(1):7-17. PubMed ID: 9864394 [TBL] [Abstract][Full Text] [Related]
3. Immunogenic comparison for two different recombinant chimeric peptides (CP12 and CP22) containing one or two copies of three linear B cell epitopes from β-hCG subunit. He YP; Xu WX; Hong AZ; Liao MC; Ji CN; Gu SH; Chen JZ; Xie Y J Biotechnol; 2011 Jan; 151(1):15-21. PubMed ID: 21084058 [TBL] [Abstract][Full Text] [Related]
4. Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin. Purswani S; Talwar GP Vaccine; 2011 Mar; 29(12):2341-8. PubMed ID: 21272600 [TBL] [Abstract][Full Text] [Related]
5. [Antigenic determinants of human chorionic gonadotropin (hCG): identification of epitopes and determination of their biological functions, for use in immunometric test systems and development of a fertility regulating vaccine]. Dirnhofer S; Gerth R; Madersbacher S; Wick G; Berger P Wien Klin Wochenschr; 1993; 105(11):314-9. PubMed ID: 7687404 [TBL] [Abstract][Full Text] [Related]
6. The human chorionic gonadotropin-beta arginine68 to glutamic acid substitution fixes the conformation of the C-terminal peptide. Charrel-Dennis M; Terrazzini N; McBride JD; Kaye P; Martensen PM; Justesen J; Berger P; Lapthorn A; Kelly C; Roitt IM; Delves PJ; Lund T Mol Endocrinol; 2005 Jul; 19(7):1803-11. PubMed ID: 15718290 [TBL] [Abstract][Full Text] [Related]
7. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters. Cole LA; Butler SA J Reprod Med; 2008 Jul; 53(7):499-512. PubMed ID: 18720925 [TBL] [Abstract][Full Text] [Related]
8. Birth control vaccines and immunological approaches to the therapy of noninfectious diseases. Stevens VC Infect Dis Clin North Am; 1990 Jun; 4(2):343-54. PubMed ID: 2345290 [TBL] [Abstract][Full Text] [Related]
9. Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits. Talwar GP; Gupta JC; Shankar NV Am J Reprod Immunol; 2011 Jul; 66(1):26-39. PubMed ID: 21501278 [TBL] [Abstract][Full Text] [Related]
10. Time-dependent folding of immunological epitopes of the human chorionic gonadotropin beta-subunit. Roig J; Krause JM; Berger P; Merz WE Mol Cell Endocrinol; 2007 Jan; 260-262():12-22. PubMed ID: 17059865 [TBL] [Abstract][Full Text] [Related]
11. Prevention of nodules and enhancement of antibody response to genetically engineered recombinant vaccine against Human Chorionic Gonadotropin (hCG) for contraception. Tiwari P; Srivastava M; Sehgal R; Kumar S; Selvapandiyan A; Kumari A; Gupta JC; Talwar GP Eur J Contracept Reprod Health Care; 2024 Aug; 29(4):182-187. PubMed ID: 38904162 [TBL] [Abstract][Full Text] [Related]
12. Molecular adjuvant C3d3 improved the anti-hCGbeta humoral immune response in vaginal inoculation with live recombinant Lactobacillus expressing hCGbeta-C3d3 fusion protein. Yao XY; Yuan MM; Li DJ Vaccine; 2007 Aug; 25(32):6129-39. PubMed ID: 17629363 [TBL] [Abstract][Full Text] [Related]
13. Tissue vaccines for cancer. Suckow MA; Heinrich J; Rosen ED Expert Rev Vaccines; 2007 Dec; 6(6):925-37. PubMed ID: 18377356 [TBL] [Abstract][Full Text] [Related]
14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011 [TBL] [Abstract][Full Text] [Related]
15. Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit. Jackson AM; Klonisch T; Lapthorn AJ; Berger P; Isaacs NW; Delves PJ; Lund T; Roitt IM J Reprod Immunol; 1996 Aug; 31(1-2):21-36. PubMed ID: 8887120 [TBL] [Abstract][Full Text] [Related]
16. A novel monoclonal antibody with catalytic activity against beta human chorionic gonadotropin. Mirshahi M; Shamsipour F; Mirshahi T; Khajeh K; Naderi-Manesh H Immunol Lett; 2006 Jul; 106(1):57-62. PubMed ID: 16759712 [TBL] [Abstract][Full Text] [Related]
17. The major hormone-specific discontinuous epitopes on human chorionic gonadotrophin. Charrel-Dennis M; Jackson AM; Lund T; Lapthorn AJ; Berger P; Roitt IM; Delves PJ J Mol Endocrinol; 2004 Apr; 32(2):571-81. PubMed ID: 15072560 [TBL] [Abstract][Full Text] [Related]
18. Targeting vaccinia virus-expressed secretory beta subunit of human chorionic gonadotropin to the cell surface induces antibodies. Srinivasan J; Singh O; Chakrabarti S; Talwar GP Infect Immun; 1995 Dec; 63(12):4907-11. PubMed ID: 7591154 [TBL] [Abstract][Full Text] [Related]
19. [Immuno-contraceptive vaccines]. Kochanowska IE; Szewczuk A Postepy Hig Med Dosw; 1995; 49(4):451-68. PubMed ID: 8657642 [TBL] [Abstract][Full Text] [Related]
20. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle. Zimmermann G; Ackermann W; Alexander H Biol Reprod; 2009 May; 80(5):1053-65. PubMed ID: 19164178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]